PRED.......
Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman
BY GlobeNewswire
— 9:00 AM ET 10/30/2018
Sorrentino Expands Role to Support Goal of Bringing Innovative Technologies to Market
SALT LAKE CITY , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. ( PRED
Loading...
Loading...
) , a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that John E. Sorrentino has been named Chairman of the Board in addition to his role as Chair of the Predictive Scientific Advisory Board. Sorrentino has more than 35 years of senior management experience in the life sciences industry and serves as Vice President and Chief Operating Officer of Pfizer Vaccine Research and Development. He replaced Merle Ferguson, who will continue as a Director of the Company.
Sorrentino brings vast experience in R&D, commercialization and clinical laboratory management and has served in leadership positions in public and private companies. Prior to joining Wyeth/Pfizer 15 years ago, he held executive positions in several organizations that provided neonatal screening and related clinical services. Sorrentino is a noted expert in the healthcare industry, having presented to state legislatures, the U.S. Congress and professional societies on a variety of healthcare and policy issues.
“We are pleased to have John expand his involvement at our Company’s most senior level, as we introduce our first endometriosis risk test, ARTguide™,” said Bradley C. Robinson, CEO of Predictive Technology Group ( PRED
Loading...
Loading...
). “John's experience, commitment and passion to delivering improved, more comprehensive healthcare to patients will be of tremendous assistance in ensuring Predictive delivers on our mission of preventing or eliminating disease for generations to come. We thank Merle for serving as Chairman and are delighted he will continue to serve as a Board member.”
“We could not have found a more qualified and committed individual to serve as Chairman and lead the company’s corporate governance,” said Ferguson. “As a longtime friend, I have seen first-hand John’s commitment to improving healthcare. I look forward to his guidance as Predictive advances cutting-edge technologies to commercialization and we seek to list our securities on a national exchange.”
